Type 2 diabetes. Abnormal glucose
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Women with type 2 Diabetes Age 20-55 years Marriage at least one year ago Living with partner Lack of polygamy Duration of diabetes more than 6 months and lack advanced diabetes complications (renal failure with creatinine greater than 1.5, severe autonomic neuropathy affecting sexual function, visual impairment, advanced vascular disorders HbA1C 6.5% - 8.5% Non-temporary marriage Body mass index between 20-35 kg/m2 No severe marital conflicts No smoking, no alcohol and tobacco consumption No pregnancy and lactation Lack of menopause Not using the medication effective on sexual function (antihistamines, barbiturates, amphetamines, narocotases, benzodiazepines, hallucinogens, SSRIs, antipsychotics and clomipyramines from the TCA group No hormone Therapy (estrogen and progesterone) No history of uncontrolled thyroid disorders Stroke and cardiovascular disease, cancer, acute liver failure, seizure, acute psychiatric disorder (including severe depression, severe anxiety through the questionnaire), multiple sclerosis
Exclusion criteria
Exclusion criteria: Receiving any treatment in the field of sexuality (both medicinal and non-pharmaceutical) during the study Missing more than two sessions of education Pregnancy during the study Taking medications affecting sexual function (antihistamines, barbiturates, amphetamines, Narcotics, benzodiazepines, hallucinogens, SSRIs, antipsychotics, and clomipyramines from the TCA class) During the study Hormone therapy (estrogen and progesterone) during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function. Timepoint: Before, immediately and eight weeks after the intervention. Method of measurement: For evaluation of sexual function, the Persian version of the Women's Sexual Function Index (FSFI) will be used. | — |
Countries
Iran (Islamic Republic of)
Contacts
Sari University of Medical Sciences